1. Home
  2. JAKK vs IKT Comparison

JAKK vs IKT Comparison

Compare JAKK & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JAKKS Pacific Inc.

JAKK

JAKKS Pacific Inc.

HOLD

Current Price

$20.26

Market Cap

233.2M

ML Signal

HOLD

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.75

Market Cap

240.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAKK
IKT
Founded
1995
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.2M
240.1M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
JAKK
IKT
Price
$20.26
$1.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$35.00
$5.00
AVG Volume (30 Days)
62.2K
1.3M
Earning Date
04-28-2026
03-26-2026
Dividend Yield
4.96%
N/A
EPS Growth
N/A
57.76
EPS
0.86
N/A
Revenue
$331,249,000.00
N/A
Revenue This Year
$9.46
N/A
Revenue Next Year
$4.36
$33.33
P/E Ratio
$23.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.87
$1.33
52 Week High
$23.25
$2.37

Technical Indicators

Market Signals
Indicator
JAKK
IKT
Relative Strength Index (RSI) 52.65 50.86
Support Level $19.16 $1.77
Resistance Level $21.06 $1.88
Average True Range (ATR) 0.74 0.12
MACD -0.04 -0.01
Stochastic Oscillator 59.55 46.94

Price Performance

Historical Comparison
JAKK
IKT

About JAKK JAKKS Pacific Inc.

Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells, and distributes toys and related kid-targeted consumer products, including kids' indoor and outdoor furniture, costumes, and various product lines in the sporting goods and home furnishings space. Its product offerings include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: Toys/Consumer Products and Costumes. It generates the majority of its revenue from the Toys/Consumer Products segment.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: